MX2008015662A - Nuevos receptores antagonistas de la hormona concentradora de melanina (mch). - Google Patents

Nuevos receptores antagonistas de la hormona concentradora de melanina (mch).

Info

Publication number
MX2008015662A
MX2008015662A MX2008015662A MX2008015662A MX2008015662A MX 2008015662 A MX2008015662 A MX 2008015662A MX 2008015662 A MX2008015662 A MX 2008015662A MX 2008015662 A MX2008015662 A MX 2008015662A MX 2008015662 A MX2008015662 A MX 2008015662A
Authority
MX
Mexico
Prior art keywords
phenyl
methoxy
chloro
thieno
pyridin
Prior art date
Application number
MX2008015662A
Other languages
English (en)
Spanish (es)
Inventor
Kevin Matthew Gardinier
Erik James Hembre
Yen Dao
David Joseph Garmene
Steven James Green
Brian Macklin Arnold
Jianliang Lu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2008015662A publication Critical patent/MX2008015662A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2008015662A 2006-06-08 2007-06-08 Nuevos receptores antagonistas de la hormona concentradora de melanina (mch). MX2008015662A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81184106P 2006-06-08 2006-06-08
PCT/US2007/070662 WO2007146758A2 (en) 2006-06-08 2007-06-08 Novel mch receptor antagonists

Publications (1)

Publication Number Publication Date
MX2008015662A true MX2008015662A (es) 2009-01-12

Family

ID=38651254

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008015662A MX2008015662A (es) 2006-06-08 2007-06-08 Nuevos receptores antagonistas de la hormona concentradora de melanina (mch).

Country Status (10)

Country Link
US (2) US8263772B2 (cg-RX-API-DMAC7.html)
EP (1) EP2029609A2 (cg-RX-API-DMAC7.html)
JP (1) JP5198439B2 (cg-RX-API-DMAC7.html)
CN (1) CN101454328A (cg-RX-API-DMAC7.html)
AU (1) AU2007257922A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0712680A2 (cg-RX-API-DMAC7.html)
CA (1) CA2652385A1 (cg-RX-API-DMAC7.html)
EA (1) EA015127B1 (cg-RX-API-DMAC7.html)
MX (1) MX2008015662A (cg-RX-API-DMAC7.html)
WO (1) WO2007146758A2 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102264737A (zh) * 2008-12-23 2011-11-30 雅培制药有限公司 抗病毒化合物
RU2505539C2 (ru) 2008-12-23 2014-01-27 Эбботт Лэборетриз Антивирусные соединения
BRPI0923527A2 (pt) 2008-12-24 2016-08-09 Syngenta Ltd métodos de preparo de fungicidas
WO2010120935A1 (en) * 2009-04-15 2010-10-21 Abbott Laboratories Anti-viral compounds
US9394279B2 (en) 2009-06-11 2016-07-19 Abbvie Inc. Anti-viral compounds
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
US8716454B2 (en) 2009-06-11 2014-05-06 Abbvie Inc. Solid compositions
EP2853531A3 (en) * 2009-06-11 2015-08-12 AbbVie Bahamas Ltd. Antiviral compounds
NZ605440A (en) 2010-06-10 2014-05-30 Abbvie Bahamas Ltd Solid compositions comprising an hcv inhibitor
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US9034832B2 (en) 2011-12-29 2015-05-19 Abbvie Inc. Solid compositions
US20150065343A1 (en) 2012-04-02 2015-03-05 Basf Se Acrylamide compounds for combating invertebrate pests
BR112014027133A2 (pt) 2012-05-09 2017-06-27 Basf Se compostos, composição agrícola ou veterinária, método para o controle das pragas de invertebrados, material de propagação dos vegetais e método para o tratamento ou proteção de um animal.
PT2970205T (pt) 2013-03-14 2019-08-26 Tolero Pharmaceuticals Inc Inibidores da jak2 e da alk2 e métodos para a sua utilização
US11484534B2 (en) 2013-03-14 2022-11-01 Abbvie Inc. Methods for treating HCV
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
AR102849A1 (es) * 2015-03-09 2017-03-29 Astellas Pharma Inc Compuesto de piridina bicíclica
PE20180572A1 (es) 2015-06-18 2018-04-04 Cephalon Inc Derivados de piperidina 1,4-sustituidos
EP3310773B1 (en) 2015-06-18 2020-12-02 89Bio Ltd. Substituted 4-benzyl and 4-benzoyl piperidine derivatives
KR20210038906A (ko) 2018-07-26 2021-04-08 스미토모 다이니폰 파마 온콜로지, 인크. 비정상적 acvr1 발현과 연관된 질환을 치료하는 방법 및 그에 사용하기 위한 acvr1 억제제
EP3873474A4 (en) 2018-10-30 2022-07-13 Nuvation Bio Inc. HETEROCYCLIC COMPOUNDS USED AS BET INHIBITORS
JP7465945B2 (ja) * 2019-07-02 2024-04-11 ニューベイション・バイオ・インコーポレイテッド Bet阻害剤としてのヘテロ環式化合物
WO2024020034A1 (en) * 2022-07-20 2024-01-25 Arcus Biosciences, Inc. Cbl-b inhibitors and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002003370A (ja) * 1999-09-20 2002-01-09 Takeda Chem Ind Ltd メラニン凝集ホルモン拮抗剤
US20020099073A1 (en) * 2000-07-07 2002-07-25 Andersen Henrik Sune Modulators of protein tyrosine phosphatases (PTPases)
GB0124627D0 (en) * 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
US20060194871A1 (en) * 2003-04-11 2006-08-31 Barvian Kevin K Heterocyclic mchr1 antagoists
JP2007509158A (ja) * 2003-10-23 2007-04-12 グラクソ グループ リミテッド 肥満、糖尿病、うつ病及び不安を治療するためのmchr1アンタゴニストとしての3−(4−アミノフェニル)チエノピリミド−4−オン誘導体
WO2005047293A1 (en) 2003-11-07 2005-05-26 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
BRPI0507629A (pt) * 2004-02-13 2007-07-03 Banyu Pharma Co Ltd composto, antagonista do receptor e agonista inverso do receptor da histamina h3, agente profilático ou terapêutico para uma doença metabólica, uma doença circulatória ou uma doença do sistema nervoso, ou um seu sal farmaceuticamente aceitável
US20050256124A1 (en) * 2004-04-15 2005-11-17 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
BRPI0512252A (pt) 2004-06-18 2008-02-19 Biolipox Ab composto ou um sal farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto
ATE446962T1 (de) * 2004-12-17 2009-11-15 Lilly Co Eli Thiazolopyridinon-derivate als mch- rezeptorantagonisten
CA2636617A1 (en) * 2006-02-15 2007-08-23 Lothar Schwink Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
RU2008136898A (ru) * 2006-02-15 2010-03-20 Санофи-Авентис (Fr) Азациклил-замещенные арилдигидроизохинолиноны, способ их получения и их применение в качестве лекарственных средств

Also Published As

Publication number Publication date
WO2007146758A3 (en) 2008-02-07
US8263772B2 (en) 2012-09-11
JP5198439B2 (ja) 2013-05-15
US20090093456A1 (en) 2009-04-09
EA200870517A1 (ru) 2009-04-28
CA2652385A1 (en) 2007-12-21
BRPI0712680A2 (pt) 2012-11-20
WO2007146758A2 (en) 2007-12-21
AU2007257922A1 (en) 2007-12-21
US20120302547A1 (en) 2012-11-29
EA015127B1 (ru) 2011-06-30
JP2009539875A (ja) 2009-11-19
CN101454328A (zh) 2009-06-10
EP2029609A2 (en) 2009-03-04

Similar Documents

Publication Publication Date Title
US8263772B2 (en) MCH receptor antagonists
AU2005316314B2 (en) Thiazolopyridinone derivates as MCH receptor antagonists
ES2373680T3 (es) Derivados de tiazol condensados como inhibidores de cinasa.
CZ2004498A3 (cs) Pyrimidinonové deriváty, způsob výroby a farmaceutický prostředek
CN121568930A (zh) 化合物及其作为抗癌药的用途
US20040024210A1 (en) New compounds
RU2418803C2 (ru) Конденсированное гетероциклическое производное, содержащая его лечебная композиция и ее применение в медицине
NZ552283A (en) New compounds useful for the treatment of obesity, type II diabetes and CNS disorders
WO2010002802A1 (en) Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity
AU2008256859A1 (en) 4' substituted compounds having 5-HT6 receptor affinity
US20080200471A1 (en) 6' substituted compounds having 5-ht6 receptor affinity
WO2008076562A1 (en) 5- [4- (azetidin-3-yl0xy) -phenyl] -2-phenyl-5h-thiaz0l0 [5,4-c] pyridin-4-0ne derivatives and their use as mch receptor antagonists
CA2536107A1 (en) Substituted piperazines of azepines, oxazepines, and thiazepines
NZ549386A (en) (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor
MX2008015486A (es) Nuevos receptores antagonistas de la hormona concentrador de melanina (mch).
TW201116531A (en) Ring-annulated dihydropyrrolo[2,1-a]isoquinolines
WO1997017349A1 (en) Five-membered fused heterocyclic azepine derivatives and pharmaceutical use thereof
EP1897881A2 (en) Compounds useful for the treatment of obesity, type II diabetes and CNS disorders